Our results indicate that overexpression of GM50337-Scd1 identified from our PyMT mouse model unravels a specific human lncRNA target, OLMALINC, which has the potential to impact human BC initiation and progression via PTHrP regulation. The gene discussed is SCD; the disease is breast cancer.